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CASE REPORT
Sudan red dye: a new agent causing type-2 
occupational asthma
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Abstract 
Background: Sudan red or 1‑[(2‑methoxyphenyl)azo]‑2‑naphthol is a low molecular weight azoic agent widely used 
in industry, particularly in the production of hair dyes. The use of this product in the food industry is prohibited due to 
its potential carcinogenic effect, but no respiratory involvement has been reported to date.
Case presentation: We present the case of a 46‑year‑old female patient who had been working in a cosmetics 
packaging company for 20 years. The patient developed occupational asthma to a red azo dye known as Sudan 
red. The diagnosis was confirmed by specific bronchial provocation test. Induced sputum samples were obtained 
previously and in the 24 h following the procedure, with a rise in the percentage of eosinophils from 10 to 65%.
Conclusions: This report describes the case of a patient who developed OA caused by exposure to an azoic dye 
called Sudan red. The clinical and analytical features suggest a type 2‑related asthma; however, we are not yet able 
to confirm the specific pathophysiological mechanism. The extensive use of azo dyes in industry means that it is 
particularly important to describe their implications for health, which are probably underestimated at present.
Keywords: Allergy, Specific inhalation challenge, Azoic agent
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
Occupational asthma (OA) is a work-related condition 
characterized by variable airflow obstruction and/or by 
bronchial hyperresponsiveness to the conditions of a 
specific working environment. Hundreds of agents are 
known developers of OA, among them more than 100 
chemical entities, whose mechanism of action is often 
unknown [1, 2].
Various dyestuffs are considered to be causes of 
occupational respiratory diseases, which are mainly 
described in workers in textile and cosmetic industries 
[3–11]. Azoic dyes, which are synthesized from primary 
aromatic amines, are the most extensively used synthetic 
organic colorants worldwide [12]. Despite the widespread 
use of these products, there are few reports of their 
relationship to OA and it is likely that dyestuff-related 
OA is underdiagnosed.
Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol 
is a low molecular weight azoic agent widely used in 
industry, particularly in the production of hair dyes. The 
use of this product in the food industry is prohibited due 
to its potential carcinogenic effect, but no respiratory 
involvement has been reported to date [13].
Case presentation
We report the case of a 46-year-old female non-smoker 
without medical history of interest, who had been 
working in a cosmetics packaging company for 20 years. 
She had undergone daily exposure to several substances 
including a red azo dye known as Sudan red.
Over the past 15  years, the patient had experienced 
dyspnea, dry cough, occasional wheezing, facial 
edema, rhinitis and conjunctivitis. These symptoms 
had worsened in the last 3  years; she had frequently 
required emergency-room assistance for acute episodes 
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of bronchospasm and had been admitted to hospital on 
four times. The patient’s symptoms responded to inhaled 
long acting beta-2 agonist and inhaled corticosteroids, 
and were clearly work-related since they improved on 
weekends, during vacations, and after she finally left her 
job.
Physical examination and chest radiograph were 
normal. Blood tests showed eosinophilia (500 cells/mm3) 
and increased total serum IgE (846 KU/L). Lung function 
study revealed an obstructive ventilatory pattern with 
a forced vital capacity (FVC) of 3.14  L (91%), a forced 
expiratory volume in one second (FEV1) of 2.12 L (76%) 
and FEV1/FVC of 67%. Methacholine challenge test was 
positive, with a PC20 of 0.85  mg/mL and a fractional 
exhaled nitric oxide test (FENO) of 47.2 ppb.
With a suspected diagnosis of OA, the patient 
underwent a specific inhalation challenge (SIC) with 
the azoic dye, in accordance with the recommendations 
in the European Respiratory Society guidelines [14]. 
The patient was exposed to a mixture of 2  g of “Sudan 
Red” and 100 g of lactose powder, tipped from one tray 
to another 30  cm away from her face for 10  min; she 
continued treatment with inhaled long acting beta-2 
agonist and inhaled corticosteroids due to the persistence 
of bronchospasm. During the procedure, she suffered 
dyspnea and cough, and experienced a dual positive 
response with a fall in FEV1 of 22% in the first 20 min and 
another of 33% approximately 10 h after the exposure. No 
significant changes in FEV1 were observed in response to 
a control challenge of lactose powder alone conducted on 
a separate day (Fig. 1).
Induced sputum samples were obtained previously and 
in the 24  h following the procedure, with a rise in the 
percentage of eosinophils from 10 to 65%. Methacholine 
and FENO tests did not present significant variations 
from the results obtained prior to the SIC. The diagnosis 
of OA due to Sudan Red was established, and the patient 
was advised to avoid the causal agent.
Discussion
To our knowledge, this is the first reported case of OA 
caused by Sudan red dye. The increase of eosinophils 
in induced sputum is a particularly relevant finding, 
since it strongly suggests a type 2 mechanism of airway 
inflammation.
Since the first reports of dye-induced OA in 1978 by 
Alanko et  al. [8], several cases have been published, 
most of them caused by exposure to reactive dyes 
in textile industries. In the early 1990s, on the basis 
of positive skin prick and RAST-inhibition tests in 
workers who developed allergic lower respiratory 
symptoms, authors such as Park HS [10], Docker 
[7] and Nilsson [3] proposed an IgE-mediated 
immunological mechanism. It was suggested that 
airborne dye molecules may act as haptens and induce 
IgE-mediated hypersensitivity reactions, However, 
none of these reports obtained cytological analysis in 
induced sputum.
Various pathophysiological pathways have been 
described in OA, depending on whether it is induced 
by a sensitizing or an irritant agent. While irritant-
induced asthma is attributed to a non-immunological 
mechanism, sensitizing agents induce asthma through 
mechanisms which may or may not be type-2-
dependent. In fact, a recent study showed that both 
high-molecular-weight agents (with an IgE-mediated 
mechanism) and low-molecular-weight agents (with as 
yet undefined mechanisms) may generate eosinophilic 
or neutrophilic responses [15].
In the present case report, the rise of eosinophils in 
induced sputum after the SIC suggests the involvement 
of a type-2 mechanism of airway inflammation. In 
addition, the presence of high levels of IgE and the 
dual positive response to the SIC may support an IgE-
mediated mechanism and consequently a possible 
Th2 enrollment. However, the increase in eosinophils 
cannot rule out a response mediated by innate 
lymphocytic immunity (ILC2) or a combination of 
both.
Conclusions
This report describes the case of a patient who 
developed OA caused by exposure to an azoic dye 
called Sudan red. The clinical and analytical features 
suggest a type 2-related asthma; however, we are not 
yet able to confirm the specific pathophysiological 
mechanism. The extensive use of azo dyes in industry 
means that it is particularly important to describe 
their implications for health, which are probably 
underestimated at present.
Fig. 1 Result of specific inhalation challenge to Sudan red
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